Advancing Care in XLH: Applying Newly Published Int'l Treatment Guidelines

Advancing Care in XLH: Applying Newly Published Int'l Treatment Guidelines is organized by EXCEL Continuing Education and will be held on Oct 10, 2026 at Hynes Convention Center, Boston, Massachusetts, United States of America.

Educational Objectives:
At the conclusion of this conference, you should be able to:

• Recognize the age-specific clinical, biochemical, and radiographic features of XLH in pediatric and adult patients to reduce diagnostic delay and misdiagnosis
• Implement guideline-recommended diagnostic and monitoring strategies, including interpretation of phosphate metabolism, FGF23-related abnormalities, and long-term surveillance for disease complications
• Assess the comparative benefits, limitations, and clinical indications of conventional therapy vs. Burosumab to guide evidence-based treatment selection and guidelines recommendations
• Integrate international XLH clinical practice guidelines into individualized management plans that address skeletal health, pain, functional outcomes, and quality of life across the lifespan